Active Ingredient: HALOBETASOL PROPIONATE; TAZAROTENE
Proprietary Name: DUOBRII
Dosage Form; Route of Administration: LOTION; TOPICAL
Strength: 0.01%;0.045%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N209354
Product Number: 001
Approval Date: Apr 25, 2019
Applicant Holder Full Name: BAUSCH HEALTH AMERICAS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
